Deutsche Bank
PARN

Deutsche Bank’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Deutsche Bank’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,824
Closed -$8K – 5638
2016
Q1 		$8K Buy
+3,824
New +$10.6K ﹤0.01% 4892
2015
Q1 		– Sell
-35,240
Closed -$146K – 6576
2014
Q4 		$146K Hold
35,240
– – ﹤0.01% 4475
2014
Q3 		$202K Buy
+35,240
New +$212K ﹤0.01% 4066

Other funds holding PARN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Deutsche Bank's PARN Position: Q2 2016 in Review

Deutsche Bank sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q2 2016, closing a stake of 3,824 shares — an estimated $8K sold.

Deutsche Bank first reported a position in PARN in Q3 2014 and held it in 3 quarters. The position peaked at $202K in Q3 2014. 19 funds tracked by Wall St. Rank hold PARN as of Q2 2016.

  • Deutsche Bank reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q2 2016 after selling out during the quarter.
  • Deutsche Bank sold 3,824 Parnell Pharmaceuticals Holdings Ltd shares in Q2 2016, an estimated $8K.
  • Deutsche Bank first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q3 2014 and held it in 3 quarters.
  • Deutsche Bank's Parnell Pharmaceuticals Holdings Ltd position peaked at $202K in Q3 2014.
  • 19 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q2 2016.

Based on Deutsche Bank's 13F filing for Q2 2016, filed 15 Aug 2016.